[1] |
SUNG H, FERLAY J, SIEGEL R L, et al. Global cancer statistics 2020:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2021, 71(3):209-249.
DOI
URL
|
[2] |
ARNOLD M, SIERRA M S, LAVERSANNE M, et al. Global patterns and trends in colorectal cancer incidence and mortality[J]. Gut, 2017, 66(4):683-691.
DOI
URL
|
[3] |
WANG Y, CHEN P M, LIU R B. Advance in plasma SEPT9 gene methylation assay for colorectal cancer early detection[J]. World J Gastrointest Oncol, 2018, 10(1):15-22.
DOI
URL
|
[4] |
JONES P A. Functions of DNA methylation:islands,start sites,gene bodies and beyond[J]. Nat Rev Genet, 2012, 13(7):484-492.
|
[5] |
MAHUL B A, STEPHEN E, FREDERICK L G, et al. AJCC cancer staging manual[M]. 8th ed. New York: Springer, 2016.
|
[6] |
SONG L, CHEN Y, GONG Y, et al. Opportunistic screening and survival prediction of digestive cancers by the combination of blood mSEPT9 with protein markers[J]. Ther Adv Med Oncol, 2020, 12:1758835920962966.
|
[7] |
TÓTH K, GALAMB O, SPISÁK S, et al. The influence of methylated septin 9 gene on RNA and protein level in colorectal cancer[J]. Pathol Oncol Res, 2011, 17(3):503-509.
DOI
URL
|
[8] |
CHURCH T R, WANDELL M, LOFTON-DAY C, et al. Prospective evaluation of methylated SEPT9 in plasma for detection of asymptomatic colorectal cancer[J]. Gut, 2014, 63(2):317-325.
DOI
URL
|
[9] |
柏愚, 杨帆, 马丹, 等. 中国早期结直肠癌筛查及内镜诊治指南(2014年,北京)[J]. 胃肠病学, 2015, 20(6):345-365.
|
[10] |
SUBKHANGULOVA A, MALIK A R, HERMEY G, et al. SORCS1 and SORCS3 control energy balance and orexigenic peptide production[J]. EMBO Rep, 2018, 19(4):e44810.
|
[11] |
RIBEIRO L F, VERPOORT B, NYS J, et al. SorCS1-mediated sorting in dendrites maintains neurexin axonal surface polarization required for synaptic function[J]. PLoS Biol, 2019, 17(10):e3000466.
|
[12] |
REITZ C, TOKUHIRO S, CLARK L N, et al. SORCS1 alters amyloid precursor protein processing and variants may increase Alzheimer's disease risk[J]. Ann Neurol, 2011, 69(1):47-64.
DOI
URL
|
[13] |
GOODARZI M O, LEHMAN D M, TAYLOR K D, et al. SORCS1:a novel human type 2 diabetes susceptibility gene suggested by the mouse[J]. Diabetes, 2007, 56(7):1922-1999.
DOI
URL
|
[14] |
LAZAR J, O'MEARA C C, SARKIS A B, et al. SORCS1 contributes to the development of renal disease in rats and humans[J]. Physiol Genomics, 2013, 45(16):720-728.
DOI
URL
|
[15] |
HUANG P Z, PENG S Y, YU H C, et al. Decreased expression of SorCS1 in colorectal cancer:an independent predictor of poor prognosis[J]. Neoplasma, 2020, 67(1):119-128.
DOI
URL
|
[16] |
ROSELLI S, PUNDAVELA J, DEMONT Y, et al. Sortilin is associated with breast cancer aggressiveness and contributes to tumor cell adhesion and invasion[J]. Oncotarget, 2015, 6(12):10473-10486.
DOI
URL
|
[17] |
GHAEMIMANESH F, AHMADIAN G, TALEBI S, et al. The effect of sortilin silencing on ovarian carcinoma cells[J]. Avicenna J Med Biotechnol, 2014, 6(3):169-177.
|
[18] |
ABDUL AZIZ N A, MOKHTAR N M, HARUN R, et al. A 19-gene expression signature as a predictor of survival in colorectal cancer[J]. BMC Med Genomics, 2016, 9(1):58.
DOI
URL
|
[19] |
SCHNEIDER B G, MERA R, PIAZUELO M B, et al. DNA methylation predicts progression of human gastric lesions[J]. Cancer Epidemiol Biomarkers Prev, 2015, 24(10):1607-1613.
DOI
URL
|
[20] |
LARSEN J V, HERMEY G, SØRENSEN E S, et al. Human sorCS1 binds sortilin and hampers its cellular functions[J]. Biochem J, 2014, 457(2):277-288.
DOI
URL
|
[21] |
SAVAS J N, RIBEIRO L F, WIERDA K D, et al. The sorting receptor SorCS1 regulates trafficking of neurexin and AMPA receptors[J]. Neuron, 2015, 87(4):764-780.
DOI
URL
|
[22] |
LARSEN J V, KRISTENSEN A M, PALLESEN L T, et al. Cytokine-like factor 1,an essential facilitator of cardiotrophin-like cytokine:ciliary neurotrophic factor receptor α signaling and sorLA-mediated turnover[J]. Mol Cell Biol, 2016, 36(8):1272-1286.
DOI
URL
|
[23] |
李丹, 苏光建, 肖燕萍, 等. 外周血甲基化Septin-9检测对结直肠癌诊断价值的Meta分析[J]. 中国免疫学杂志, 2017, 33(10):1547-1551.
|
[24] |
BERGHEIM J, SEMAAN A, GEVENSLEBEN H, et al. Potential of quantitative SEPT9 and SHOX2 methylation in plasmatic circulating cell-free DNA as auxiliary staging parameter in colorectal cancer:a prospective observational cohort study[J]. Br J Cancer, 2018, 118(9):1217-1228.
DOI
URL
|